Home GSK to buy HIV drugs from Bristol-Myers Squibb for initial $350 million
 

Keywords :   


GSK to buy HIV drugs from Bristol-Myers Squibb for initial $350 million

2015-12-18 11:02:16| Biotech - Topix.net

It used to dominate the market but ViiV's 2014 sales of 1.5 billion pounds were less than a quarter of the HIV revenue generated by market leader Gilead Sciences ViiV will pay an initial $317 million to buy late-stage HIV drug candidates from Bristol-Myers, including a phase III development treatment fostemsavir, plus $33 million for its preclinical assets. HIV is often treated by mixing at least three medicines together because of the ability of the virus that causes AIDS to mutate and become drug-resistant.

Tags: buy million initial drugs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
22.11SHIMANO BT Master 11AP)
22.11
22.11
22.11GOLDWIN
22.11Qi10 TOUR 5W WF
22.11
22.11GX HR
22.11 GEORGIA
More »